These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 3802099)

  • 21. Fractionated radioimmunotherapy of human colon carcinoma xenografts with 131I-labeled monoclonal antibody CC49.
    Buchsbaum D; Khazaeli MB; Liu T; Bright S; Richardson K; Jones M; Meredith R
    Cancer Res; 1995 Dec; 55(23 Suppl):5881s-5887s. PubMed ID: 7493364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of pre-irradiation on monoclonal antibody localization in colon tumor xenografts expressing a cell-associated antigen.
    Gridley DS; Slater JB; Slater JM
    Anticancer Res; 1995; 15(1):99-104. PubMed ID: 7733650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation between tumor-associated glycoprotein 72 mucin levels in tumor and serum of colorectal patients as measured by the quantitative CA 72-4 immunoassay.
    Guadagni F; Roselli M; Cosimelli M; Spila A; Cavaliere F; Tedesco M; Arcuri R; Abbolito MR; Casale V; Pericoli MN; Vecchione A; Casciani CU; Greiner JW; Schlom J
    Cancer Res; 1996 Nov; 56(22):5293-8. PubMed ID: 8912871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase I/II trial of combined 131I anti-CEA monoclonal antibody and hyperthermia in patients with advanced colorectal adenocarcinoma.
    Mittal BB; Zimmer MA; Sathiaseelan V; Benson AB; Mittal RR; Dutta S; Rosen ST; Spies SM; Mettler JM; Groch MW
    Cancer; 1996 Nov; 78(9):1861-70. PubMed ID: 8909304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. dUTP nucleotidohydrolase isoform expression in normal and neoplastic tissues: association with survival and response to 5-fluorouracil in colorectal cancer.
    Ladner RD; Lynch FJ; Groshen S; Xiong YP; Sherrod A; Caradonna SJ; Stoehlmacher J; Lenz HJ
    Cancer Res; 2000 Jul; 60(13):3493-503. PubMed ID: 10910061
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radioimmunoscintigraphy of colon cancer with iodine-131-labeled B72.3 monoclonal antibody.
    Carrasquillo JA; Sugarbaker P; Colcher D; Reynolds JC; Esteban J; Bryant G; Keenan AM; Perentesis P; Yokoyama K; Simpson DE
    J Nucl Med; 1988 Jun; 29(6):1022-30. PubMed ID: 3373312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced antitumor activity of combination radioimmunotherapy (131I-labeled monoclonal antibody A33) with chemotherapy (fluorouracil).
    Tschmelitsch J; Barendswaard E; Williams C; Yao TJ; Cohen AM; Old LJ; Welt S
    Cancer Res; 1997 Jun; 57(11):2181-6. PubMed ID: 9187118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Diagnosis and surgical treatment of metastatic lung tumors].
    Yamamoto Y; Hirata T; Fukuse T; Yokomise H; Ike O; Mizuno H; Wada H; Hitomi S; Nakamura T; Shimizu Y
    Gan To Kagaku Ryoho; 1996 Sep; 23(10):1248-54. PubMed ID: 8831735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of a monoclonal antibody (B72.3) as an immunocytochemical adjunct to diagnosis of adenocarcinoma in human effusions.
    Johnston WW; Szpak CA; Lottich SC; Thor A; Schlom J
    Cancer Res; 1985 Apr; 45(4):1894-900. PubMed ID: 3884146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of immunoreactivity of normal tissues from dogs, using monoclonal antibody B72.3.
    Clemo FA; DeNicola DB; Zimmermann JL
    Am J Vet Res; 1994 Aug; 55(8):1139-47. PubMed ID: 7978655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pilot trial evaluating an 123I-labeled 80-kilodalton engineered anticarcinoembryonic antigen antibody fragment (cT84.66 minibody) in patients with colorectal cancer.
    Wong JY; Chu DZ; Williams LE; Yamauchi DM; Ikle DN; Kwok CS; Liu A; Wilczynski S; Colcher D; Yazaki PJ; Shively JE; Wu AM; Raubitschek AA
    Clin Cancer Res; 2004 Aug; 10(15):5014-21. PubMed ID: 15297402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor localization in patients by radiolabeled monoclonal antibodies against colon carcinoma.
    Mach JP; Chatal JF; Lumbroso JD; Buchegger F; Forni M; Ritschard J; Berche C; Douillard JY; Carrel S; Herlyn M
    Cancer Res; 1983 Nov; 43(11):5593-600. PubMed ID: 6616486
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative analysis of antibody localization in human metastatic colon cancer: a phase I study of monoclonal antibody A33.
    Welt S; Divgi CR; Real FX; Yeh SD; Garin-Chesa P; Finstad CL; Sakamoto J; Cohen A; Sigurdson ER; Kemeny N
    J Clin Oncol; 1990 Nov; 8(11):1894-906. PubMed ID: 2230877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Binding of radiolabeled MAb B72.3 administered intravenously and intraperitoneally in colorectal cancer patients. An overview.
    Schlom J; Siler K; Colcher D; Carrasquillo JA; Reynolds JC; Sugarbaker P; Larson SM
    Acta Radiol Suppl; 1990; 374():123-8. PubMed ID: 1966958
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radioimmunodetection of colorectal cancer metastases with 131I-labeled monoclonal antibody B72.3: a pilot study to determine efficacy of detection and pharmacokinetics.
    Stern H; Reilly R; Gallinger S; Kirsh J; DeAngelis C; Papa M; Hay K; Polihronis J; Schmoker B
    Cancer Invest; 1993; 11(2):129-34. PubMed ID: 8462013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simple sugars to complex disease--mucin-type O-glycans in cancer.
    Kudelka MR; Ju T; Heimburg-Molinaro J; Cummings RD
    Adv Cancer Res; 2015; 126():53-135. PubMed ID: 25727146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeted killing of colorectal cancer cell lines by a humanised IgG1 monoclonal antibody that binds to membrane-bound carcinoembryonic antigen.
    Conaghan P; Ashraf S; Tytherleigh M; Wilding J; Tchilian E; Bicknell D; Mortensen NJ; Bodmer W
    Br J Cancer; 2008 Apr; 98(7):1217-25. PubMed ID: 18349843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epitope blocking: positive and negative effects on the biodistribution of 125I-labeled anti-Tac disulfide-stabilized Fv fragment of two antibodies against different epitopes of the circulating antigen.
    Kobayashi H; Sun BF; Han ES; Kim MK; Le N; Wang QC; Nelson DL; Pastan I; Waldmann TA; Paik CH; Carrasquillo JA
    Jpn J Cancer Res; 1998 Apr; 89(4):436-44. PubMed ID: 9617350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Specificities of anti-sialyl-Tn and anti-Tn monoclonal antibodies generated using novel clustered synthetic glycopeptide epitopes.
    Reddish MA; Jackson L; Koganty RR; Qiu D; Hong W; Longenecker BM
    Glycoconj J; 1997 Aug; 14(5):549-60. PubMed ID: 9298687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mucin glycoproteins in neoplasia.
    Kim YS; Gum J; Brockhausen I
    Glycoconj J; 1996 Oct; 13(5):693-707. PubMed ID: 8909996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.